The use of myelopid in the combined treatment of infectious-inflammatory complications in the postoperative period in neuro-oncology patients

Lisianyĭ, N.I.; Romodanov, S.A.; Radzievskiĭ, A.A.; Rudenko, V.A.; Pedachenko, E.G.

Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 3: 16-18

1991


ISSN/ISBN: 0042-8817
PMID: 1661534
Document Number: 372703
Clinical observations over 48 neurosurgical patients with infectious inflammatory complications and study of their immune status showed that a course of immunocorrective therapy with myelopid produces a favourable clinical effect and normalizes the patient's immune status. Myelopid causes the best normalizing effect in patients with nontumorous pathology of the central nervous system and in extracerebral neoplasms.

Document emailed within 1 workday
Secure & encrypted payments